The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B
- PMID: 30791110
- PMCID: PMC6618260
- DOI: 10.1002/hep.30571
The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B
Abstract
Chronic infection of hepatitis B virus (HBV) is associated with an increased incidence of hepatocellular carcinoma (HCC). HBV encodes an oncoprotein, hepatitis B x protein (HBx), that is crucial for viral replication and interferes with multiple cellular activities including gene expression, histone modifications, and genomic stability. To date, it remains unclear how disruption of these activities contributes to hepatocarcinogenesis. Here, we report that HBV exhibits antiresection activity by disrupting DNA end resection, thus impairing the initial steps of homologous recombination (HR). This antiresection activity occurs in primary human hepatocytes undergoing a natural viral infection-replication cycle as well as in cells with integrated HBV genomes. Among the seven HBV-encoded proteins, we identified HBx as the sole viral factor that inhibits resection. By disrupting an evolutionarily conserved Cullin4A-damage-specific DNA binding protein 1-RING type of E3 ligase, CRL4WDR70 , through its H-box, we show that HBx inhibits H2B monoubiquitylation at lysine 120 at double-strand breaks, thus reducing the efficiency of long-range resection. We further show that directly impairing H2B monoubiquitylation elicited tumorigenesis upon engraftment of deficient cells in athymic mice, confirming that the impairment of CRL4WDR70 function by HBx is sufficient to promote carcinogenesis. Finally, we demonstrate that lack of H2B monoubiquitylation is manifest in human HBV-associated HCC when compared with HBV-free HCC, implying corresponding defects of epigenetic regulation and end resection. Conclusion: The antiresection activity of HBx induces an HR defect and genomic instability and contributes to tumorigenesis of host hepatocytes.
© 2019 The Authors. Hepatology published by Wiley Periodicals, Inc., on behalf of American Association for the Study of Liver Diseases.
Figures








Similar articles
-
Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.J Pathol. 2015 Jul;236(3):337-47. doi: 10.1002/path.4531. Epub 2015 Apr 22. J Pathol. 2015. PMID: 25775999
-
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.Clin Microbiol Infect. 2019 Jul;25(7):906.e1-906.e7. doi: 10.1016/j.cmi.2018.11.017. Epub 2018 Nov 23. Clin Microbiol Infect. 2019. PMID: 30472417
-
Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6.Antiviral Res. 2019 Dec;172:104618. doi: 10.1016/j.antiviral.2019.104618. Epub 2019 Oct 7. Antiviral Res. 2019. PMID: 31600532
-
Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:144-52. doi: 10.1111/j.1440-1746.2010.06546.x. J Gastroenterol Hepatol. 2011. PMID: 21199526 Review.
-
The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.Front Immunol. 2021 Apr 29;12:661204. doi: 10.3389/fimmu.2021.661204. eCollection 2021. Front Immunol. 2021. PMID: 33995383 Free PMC article. Review.
Cited by
-
Expression of BRCA1, BRCA2, RAD51, and other DSB repair factors is regulated by CRL4WDR70.DNA Repair (Amst). 2022 May;113:103320. doi: 10.1016/j.dnarep.2022.103320. Epub 2022 Mar 15. DNA Repair (Amst). 2022. PMID: 35316728 Free PMC article.
-
Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection?Viruses. 2021 Sep 24;13(10):1920. doi: 10.3390/v13101920. Viruses. 2021. PMID: 34696350 Free PMC article. Review.
-
Clinical cancer immunotherapy: Current progress and prospects.Front Immunol. 2022 Oct 11;13:961805. doi: 10.3389/fimmu.2022.961805. eCollection 2022. Front Immunol. 2022. PMID: 36304470 Free PMC article. Review.
-
Cullin Ring Ubiquitin Ligases (CRLs) in Cancer: Responses to Ionizing Radiation (IR) Treatment.Front Physiol. 2019 Oct 1;10:1144. doi: 10.3389/fphys.2019.01144. eCollection 2019. Front Physiol. 2019. PMID: 31632280 Free PMC article. Review.
-
Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma.Theranostics. 2021 Jan 1;11(5):2318-2333. doi: 10.7150/thno.48739. eCollection 2021. Theranostics. 2021. PMID: 33500727 Free PMC article.
References
-
- El‐Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365:1118‐1127. - PubMed
-
- Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006;6:674‐687. - PubMed
-
- Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129‐1133. - PubMed
-
- Brechot C, Pourcel C, Louise A, Rain B, Tiollais P. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 1980;286:533‐535. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 2013CB911000/Ministry of Science and Technology of the People's Republic of China/International
- 201703D321013/Department of Science and Technology of Shanxi Province/International
- 2017FZ0034/Department of Science and Technology of Sichuan Province/International
- 31471276/National Natural Science Foundation of China/International
- 31771580/National Natural Science Foundation of China/International
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials